{
    "nctId": "NCT02602938",
    "briefTitle": "Aspirin on CTCs of Advanced Breast and Colorectal Cancer",
    "officialTitle": "N/A",
    "overallStatus": "UNKNOWN",
    "conditions": "Epithelial-Mesenchymal Transition, Circulating Tumor Cells",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NA",
    "primaryPurpose": "BASIC_SCIENCE",
    "enrollmentCount": 40,
    "primaryOutcomeMeasure": "Intervention completed",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Adults age from 18-75 years old.\n* Patients were diagnosed for metastatic breast or colorectal cancer by pathology.\n* Patients who were not currently receiving intravenous chemotherapy , oral administrated with capecitabine was permitted.\n* Concurrent endocrine therapy ( for at least 2 months before enrollment), bisphosphonate therapy, and/or monoclonal targeted therapy were permitted.\n* PS score \u2264 3\n* Anticipated survival time \u2265 3 months\n* CTCs\u22655 / 7.5ml blood\n\nExclusion Criteria:\n\n* Allergic to aspirin or other types of non-steroid\n* History of hemorrhage of digestive tract or other hemorrhagic disease\n* Plan to receive surgery within the time frame of the trial\n* Medication history of aspirin or other types of anti-platelets drug within one months before the trial\n* Women in pregnant or lactation period\n* Any psychological or objective problem may influence the compliance of the patients",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}